Page 288 - Vitamin D and Cancer

11 Vitamin D and Hematologic Malignancies 275

105. Wang X, Studzinski GP (2001) Activation of extracellular signal-regulated kinases (ERKs)
defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells.
J Cell Biochem 80(4):471–82
106. Marcinkowska E (Jan-Feb, 2001) Evidence that activation of MEKl,2/erkl,2 signal transduc-
tion pathway is necessary for calcitriol-induced differentiation of HL-60 cells. Anticancer
Res 21(lA):499–504
107. Wang X, Wang TT, White JH, Studzinski GP (Nov 9, 2006) Induction of kinase suppressor
of RAS-1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells
through a vitamin D response element in the 5¢-flanking region. Oncogene 25(53):7078–85
108. Wang X, Wang TT, White JH, Studzinski GP (Aug 15, 2007) Expression of human kinase
suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by
1,25-dihydroxyvitamin D(3) and is required for optimal cell differentiation. Exp Cell Res
313(14):3034–45
109. Wang X, Studzinski GP (Nov, 2006) Raf-l signaling is required for the later stages of
1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells but is not mediated by the
MEK/ERK module. J Cell Physiol 209(2):253–60
110. Brown G, Bunce CM, Rowlands DC, Williams GR (May, 1994) All-trans retinoic acid and
1 alpha,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promy-
eloid leukemia cell line HL60 to monocytes. Leukemia 8(5):806–15
111. Bunce CM, Wallington LA, Harrison P, Williams GR, Brown G (Mar, 1995) Treatment of
HL60 cells with various combinations of retinoids and 1 alpha,25 dihydroxyvitamin D3
results in differentiation toward neutrophils or monocytes or a failure to differentiate and
apoptosis. Leukemia 9(3):410–8
112. Masciulli R, Testa U, Barberi T, Samoggia P, Tritarelli E, Pustorino R, Mastroberardino G,
Camagna A, Peschle C (May, 1995) Combined vitamin D3/retinoic acid induction of human
promyelocytic cell lines: enhanced phagocytic cell maturation and hybrid granulomonocytic
phenotype. Cell Growth Differ 6(5):493–503
113. Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed
JC, Binderup L, Koeffler HP (Aug 1, 1996) Combination of a potent 20-epi-vitamin D3
analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases
bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res
56(15):3570–6
114. Taimi M, Chateau MT, Cabane S, Marti J (1991) Synergistic effect of retinoic acid and
1,25-dihydroxyvitamin D3 on the differentiation of the human monocytic cell line U937.
Leuk Res 15(12):1145–52
115. Doré BT, Uskokovic MR, Momparler RL (Sep, 1993) Interaction of retinoic acid and vita-
min D3 analogs on HL-60 myeloid leukemic cells. Leuk Res 17(9):749–57
116. Muto A, Kizaki M, Yamato K, Kawai Y, Kamata-Matsushita M, Ueno H, Ohguchi M,
Nishihara T, Koeffler HP, Ikeda Y (Apr 1, 1999) 1,25-Dihydroxyvitamin D3 induces dif-
ferentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-l) associ-
ated with expression of p21(WAFl/CIPl) and p27(KIPl). Blood 93(7):2225–33
117. Bastie JN, Balitrand N, Guillemot I, Chomienne C, Delva L (Nov 1, 2005) Cooperative
action of lalpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic
leukemia cell differentiation is transcriptionally controlled. Exp Cell Res 310(2):319–30
118. Cellier MF, Taimi M, Chateau MT, Cannat A, Marti J (Aug, 1993) Thermal stress as an
inducer of differentiation of U93 7 cells. Leuk Res 17(8):649–56
119. Kumagai T, Shih LY, Hughes SV, Desmond JC, O’Kelly J, Hewison M, Koeffler HP (Mar
15, 2005) 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with
arsenic trioxide, has potent antitumor activity against myeloid leukemia. Cancer Res
65(6):2488–97
120. Bunce CM, French PJ, Durham J, Stockley RA, Michell RH, Brown G (Apr, 1994)
Indomethacin potentiates the induction of HL60 differentiation to neutrophils, by retinoic
acid and granulocyte colony-stimulating factor, and to monocytes, by vitamin D3. Leukemia
8(4):595–604